natgillin/translations-raw huggingface dataset:
POWDER VIAL
BOČICA ZA PRAŠAK
Powder vial
Bočica s praškom
Powder vial 1000 IU
Bočica s praškom od 1000 IU
Powder vial 2000 IU
Bočica s praškom od 2000 IU
Powder vial 250 IU
Bočica s praškom od 250 IU
Powder vial 500 IU
Bočica s praškom od 500 IU
Powder vial also contains L-Lysine
Bočica s praškom sadrži i L-lizin
Powder vial and 5 ml solvent preassembled in BAXJECT III system.
Bočica s praškom i 5 ml otapala već pričvršćeni na sustav BAXJECT III.
Powder vial none
Bočica s praškom nema
Powder vial: 6-ml colourless glass vial, hydrolytic glass type I (Ph.
Bočica s praškom: bezbojna staklena bočica od 6 ml, staklo hidrolitičke skupine I (Ph.
Powder vial: citric acid, sodium hydroxide, disodium phosphate dihydrate, sodium chloride, sucrose.
Bočica s praškom: citratna kiselina, natrijev hidroksid, natrijev hidrogenfosfat dihidrat, natrijev klorid, saharoza
Powder vial: citric acid, sodium hydroxide, disodium phosphate dihydrate, sodium chloride, sucrose.
Bočica s praškom: citratna kiselina, natrijev hidroksid, natrijev hidrogenfosfat dihidrat, natrijev klorid, saharoza.
Powder vial: Clear, colourless type I glass vial with a butyl rubber stopper and blue flip-off seal.
Bočica s praškom: prozirna, bezbojna staklena bočica tip I s čepom od butilne gume i plavom „flip- off“ zaštitnom kapicom.
Powder vial: Type I amber glass vial with siliconised grey rubber stopper and aluminium tear off overseal with or without a blue cap.
Bočica s praškom: bočica od stakla smeđe boje tipa I sa silikoniziranim sivim gumenim čepom i aluminijskim zatvaračem s plavim poklopcem ili bez njega.
powder vials (type I glass) with a stopper (butyl rubber) and a flip-off seal pre-filled (type I glass) syringes with a stopper (butyl rubber), a rubber tip cap and a Luer Lock adapter fluid transfer device with an integral plastic spike
bočice s praškom (staklo tip I) s gumenim čepom (butilna guma) i "flip-off" prstenom napunjene štrcaljke (staklo tip I) s gumenim čepom (butilna guma), gumenim zatvaračem vrha i Luer Lock adapterom uređaj za prijenos tekućine s ugrađenim plastičnim šiljkom
Powder, dispersion and solvent for concentrate for dispersion for infusion Myocet is supplied as a three-vial system:
Prašak, disperzija i otapalo za koncentrat za disperziju za infuziju Myocet se isporučuje kao sustav od tri bočice:
Powder, solvent and matrix for implantation matrix contain: 1 vial with 12 mg dibotermin alfa
Prašak, otapalo i matrica za matricu implantata sadrži: 1 bočicu s 12 mg dibotermina alfa
Powder, solvent and matrix for implantation matrix.
Prašak, otapalo i matrica za matricu implantata.
Powder/ritonavir n=82
/ritonavirom n=82
POWDER/VIAL
PRAŠAK/BOČICA
Powder:
Prašak
Powder: 1 dose; solvent:
Prašak: 1 doza; otapalo:
powder: 1 mg (50
prašak: 1 mg (50
powder: 1.5 mg;
prašak: 1,5 mg; otapalo: 1,13 ml
Powder: 1000 IU
Prašak: 1000 IU
Powder: 1000 IU + Solvent: 2.5 ml (400 IU/ml)
Prašak: 1000 IU + Otapalo: 2.5 ml (400 IU/ml)
Powder: 1000 IU powder in 8 ml type 1 glass vial, closed with coated bromobutyl stopper and sealed with aluminium flip-off cap
Prašak: 1000 IU praška u staklenoj (tip 1) bočici od 8 ml, zatvorenoj čepom obloženim bromobutilom i hermetički zatvorenim aluminijskim "flip-off" zatvaračem
Powder: 1000 IU/2400 IU
Prašak: 1000 IU/2400 IU
powder: 1000 IU;
prašak: 1000 IU;
Powder: 1000 mg
Prašak: 1000 mg
Powder: 12 mg;
Prašak: 12 mg;
Powder: 150 mg of powder for solution for injection in a 6 ml vial (type I glass) with a stopper (coated chlorobutyl rubber) and flip-off cap (aluminium/plastic disc).
Prašak: 150 mg praška za otopinu za injekciju u bočici od 6 ml (staklo tipa I) s čepom (obložena klorobutilna guma) i „flip-off“ kapicom (aluminijski/plastični disk).
powder: 150 mg;
prašak: 150 mg;
powder: 150 mg; solvent: 2 ml
prašak: 150 mg; otapalo: 2 ml
powder: 1500 IU;
prašak: 1500 IU;
powder: 2 mg (100 KIU); (50
prašak: 2 mg (100 KIU); (50
powder: 2 mg; solvent: 1.5 ml
prašak: 2 mg; otapalo: 1,5 ml
powder: 20 mg; solvent: 1.5 ml
prašak: 20 mg; otapalo: 1,5 ml
powder: 2000 IU
prašak: 2000 IU
Powder: 2000 IU + Solvent: 5 ml (400 IU/ml)
Prašak: 2000 IU + Otapalo: 5 ml (400 IU/ml)
Powder: 2000 IU powder in 8 ml type 1 glass vial, closed with coated bromobutyl stopper and sealed with aluminium flip-off cap
Prašak: 2000 IU praška u staklenoj (tip 1) bočici od 8 ml, zatvorenoj čepom obloženim bromobutilom i hermetički zatvorenim aluminijskim "flip-off" zatvaračem
powder: 2000 IU;
prašak: 2000
powder: 2000 IU;
Prašak: 2000 IU;
powder: 210 mg;
prašak: 210 mg
powder: 250 IU
prašak: 250 IU
Powder: 250 IU powder in 8 ml type 1 glass vial, closed with coated bromobutyl stopper and sealed with aluminium flip-off cap
Prašak: 250 IU praška u staklenoj (tip 1) bočici od 8 ml, zatvorenoj čepom obloženim bromobutilom i hermetički zatvorenim aluminijskim "flip-off" zatvaračem
Powder: 250 IU/600 IU
Prašak: 250 IU/600 IU
powder: 250 IU;
250 IU
powder: 250 IU;
prašak: 250 IU;
powder: 2g gel: 20 g
gel: 20 g
Powder: 3 ml vials (Type I glass) with a stopper (bromobutyl rubber) and aluminium flip-off cap.
Prašak: bočice od 3 ml (staklo tipa I) s čepom (bromobutil guma) i aluminijskim „flip-off“ zatvaračem.
powder: 3 ml; solvent: 1.2 ml
prašak: 3 ml; otapalo: 1,2 ml
Powder: 300 mg
Prašak: 300 mg
powder: 300 mg;
prašak: 300 mg
Powder: 3000 IU
Prašak: 3000 IU
powder: 3000 IU;
3000 IU
powder: 3000 IU;
prašak: 3000
powder: 3000 IU;
prašak: 3000 IU;
Powder: 38.5 mcg
Prašak: 38,5 mcg
powder: 4 mg; solvent: 1.5 ml
prašak: 4 mg; otapalo: 1,5 ml
powder: 4 mg; solvent: 5 ml
prašak: 4 mg; otapalo: 5 ml
Powder: 400 mg
Prašak: 400 mg
powder: 405 mg; solvent: 3 ml
prašak: 405 mg otapalo: 3 ml
powder: 5 g gel: 50 g
praška: 5 g
powder: 5 mg (250 KIU); (50
prašak: 5 mg (250 KIU); (50
powder: 500 IU
prašak: 500 IU
Powder: 500 IU + Solvent: 2.5 ml (200 IU/ml)
Prašak: 500 IU + Otapalo: 2.5 ml (200 IU/ml)
Powder: 500 IU powder in 8 ml type 1 glass vial, closed with coated bromobutyl stopper and sealed with aluminium flip-off cap
Prašak: 500 IU praška u staklenoj (tip 1) bočici od 8 ml, zatvorenoj čepom obloženim bromobutilom i hermetički zatvorenim aluminijskim "flip-off" zatvaračem
Powder: 500 IU/1200 IU
Prašak: 500 IU/1200 IU
powder: 500 IU;
500 IU
powder: 500 IU;
Prašak i otapalo
powder: 500 IU;
prašak: 500 IU;
powder: 7 mg; solvent: 1.5 ml
prašak: 7 mg; otapalo: 1,5 ml
powder: 75 IU;
75 IU
powder: 75 IU;
prašak: 75 IU;
powder: 75 mg; solvent: 2 ml
prašak: 75 mg; otapalo: 2 ml
powder: 8 mg (400 KIU); (50
prašak: 8 mg (400 KIU); (50
Powder: Contains sucrose, trometamol, hydrochloric acid
Prašak: sadrži saharozu, trometamol, kloridnu kiselinu
Powder: disodium phosphate dihydrate, sodium dihydrogen phosphate monohydrate, methionine, polysorbate 20, sucrose.
Prašak: natrijev hidrogenfosfat dihidrat, natrijev dihidrogenfosfat hidrat, metionin, polisorbat 20, saharoza.
Powder: disodium phosphate, anhydrous; sodium dihydrogen phosphate dihydrate; sucrose and polysorbate 80.
Prašak: natrijev hidrogenfosfat, bezvodni; natrijev dihidrogenfosfat dihidrat, saharoza i polisorbat 80.
Powder: Do not store above 30 ºC
Prašak: Ne čuvati na temperaturi iznad 30 °C
Powder: Do not store above 30C
Prašak: Ne čuvati na temperaturi iznad 30 °C
Powder: Do not store above 30C.
Prašak: Ne čuvati na na temperaturi iznad 30 C.
Powder: Do not store above 30C.
Prašak: Ne čuvati na temperaturi iznad 30 C.
Powder: glycine, disodium hydrogen phosphate heptahydrate, sodium dihydrogen phosphate dihydrate Solvent: benzyl alcohol, water for injections
Prašak: glicin, dinatrijev hidrogenfosfat heptahidrat, natrijev dihidrogenfosfat dihidrat Otapalo: benzilni alkohol, voda za injekcije
Powder: Histidine Glycine Mannitol (E421)
Prašak: histidin glicin manitol (E421)
Powder: Mannitol
Prašak: manitol
Powder: Mannitol (E421), sucrose and trometamol
Prašak: manitol (E421), saharoza i trometamol
Powder: Mannitol (E421), sucrose and trometamol Solvent: Water for injections
Prašak: manitol (E421), saharoza i trometamol Otapalo: voda za injekcije
Powder: Sodium chloride Sucrose Histidine.
Prašak: Natrijev klorid saharoza histidin.
Powder: Sodium chloride Sucrose Polysorbate 20 L-histidine
Prašak: Natrijev klorid Saharoza Polisorbat 20 L-histidin
Powder: Sodium chloride, L-histidine, sucrose, polysorbate 80, L-methionine, calcium chloride dihydrate, sodium hydroxide, hydrochloric acid
Prašak: natrijev klorid, L-histidin, saharoza, polisorbat 80, L-metionin, kalcijev klorid dihidrat, natrijev hidroksid, kloridna kiselina
Powder: Sodium chloride, sucrose, polysorbate 20, L-histidine, hydrochloric acid (for pH- adjustment), sodium hydroxide (for pH-adjustment)
Prašak: natrijev klorid, saharoza, polisorbat 20, L-histidin, kloridna kiselina (za podešavanje pH), natrijev hidroksid (za podešavanje pH).
Powder: Sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, human serum albumin
Prašak: natrijev dihidrogenfosfat dihidrat, natrijev hidrogenfosfat dodekahidrat, humani serumski albumin
Powder: sorbitol, sodium phosphate, potassium phosphate, sucrose, hydrolysed gelatin, medium 199 with Hanks’ salts, MEM, monosodium L-glutamate, neomycin, phenol red, sodium bicarbonate, hydrochloric acid (to adjust pH), and sodium hydroxide (to adjust pH)
Prašak: sorbitol, natrijev fosfat, kalijev fosfat, saharoza, hidrolizirana želatina, podloga 199 s Hanksovim solima, MEM, natrijev L-glutamat, neomicin, fenolno crvenilo, natrijev hidrogenkarbonat, kloridna kiselina (za podešavanje pH) i natrijev hidroksid (za podešavanje pH)
Powder: Sucrose
Prašak: saharoza
Powder: sucrose, disodium phosphate dihydrate, sodium dihydrogen phosphate monohydrate, methionine, polysorbate 20, concentrated phosphoric acid and sodium hydroxide.
Prašak: saharoza, natrijev hidrogenfosfat dihidrat, natrijev dihidrogenfosfat hidrat, metionin, polisorbat 20, koncentrirana fosfatna kiselina i natrijev hidroksid.
Powder: sucrose, histidine, histidine hydrochloride monohydrate, polysorbate 80.
Prašak: saharoza, histidin, histidinklorid hidrat, polisorbat 80.
Powder: sucrose, L- histidine, mannitol, polysorbate 20, sodium hydroxide, hydrochloric acid
Prašak: saharoza, L-histidin, manitol, polisorbat 20, natrijev hidroksid, kloridna kiselina
Powder: sucrose, sorbitol
Prašak: saharoza, sorbitol
powder: vial
prašak: bočica
Powder: vial (glass)
Prašak: bočica (staklo)
Powder: vial (glass) Solution: vial (glass)
Prašak: bočica (staklo) Otopina: bočica (staklo)
Powder: vial (glass) Solvent: ampoule (glass)
Prašak: bočica (staklo) Otapalo: ampula (staklo)
Powder: vial (glass) Solvent: pre- filled syringe (glass)
Prašak: bočica (staklena) Otapalo: napunjena štrcaljka (staklena)
Powder: vial (glass) Solvent: pre-filled syringe (glass)
Prašak: bočica (staklo) otapalo: napunjena štrcaljka (staklo)
powder: vial (glass) solvent: vial (glass)
prašak: bočica (staklena) otapalo: bočica (staklena)
Powder: vial (glass) Solvent: vial (glass)
Prašak: bočica (staklo) Otapalo: bočica (staklo)
powder: vial (glass) solvent: vial (glass)
prašak: bočica (staklo) otopina: bočica (staklo)
powder: vial (glass), solvent: pre-filled syringe
Prašak: bočica (staklena), otapalo: napunjena štrcaljka
powder: vial (glass);
prašak: bočica (staklena); otapalo: bočica (staklena)
powder: vial (glass);
prašak: bočica (staklo); otapalo: bočica (staklo)
powder: vial (glass);
Prašak:bočica(staklo)
powder: vial (glass); gel: bottle (glass)
prašak: bočica
powder: vial (glass); solvent:
(staklo); otapalo: bočica (staklo); matrica: blister
powder: vial (glass); solvent: ampoule (glass)
prašak: bočica (staklena); otapalo: ampula (staklena)
powder: vial (glass); solvent: ampoule (glass)
prašak: bočica (staklo); otapalo: ampula (staklo)
Powder: vial (glass); Solvent: pre- filled syringe (glass)
Prašak: bočica (staklo); Otapalo: napunjena štrcaljka (staklo)
powder: vial (glass); solvent: pre-filled syringe
prašak: bočica (staklo); otapalo: napunjena štrcaljka (staklo)
Powder: vial (glass); solvent: pre-filled syringe (glass)
(staklena); otapalo: napunjena štrcaljka (staklena) Prašak: bočica
Powder: vial (glass); solvent: pre-filled syringe (glass)
napunjena štrcaljka
powder: vial (glass); solvent: pre-filled syringe (glass)
Prašak: bočica (staklena) Otapalo: napunjena štrcaljka (staklena)
Powder: vial (glass); Solvent: pre-filled syringe (glass)
Prašak: bočica (staklo) Otapalo: napunjena štrcaljka (staklo)
powder: vial (glass); solvent: pre-filled syringe (glass)
prašak: bočica (staklo); otapalo: napunjena štrcaljka (staklo)
powder: vial (glass); solvent: syringe (glass)
prašak: bočica (staklo); otapalo: štrcaljka (staklo)
powder: vial (glass); solvent: vial (glass)
prašak: bočica (staklo); otapalo: bočica (staklo)
Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a light-blue flip-off cap (aluminium and plastic).
Prašak: bočica (staklo tipa I) zatvorena gumenim (butilnim) čepom i svijetloplavim „flip-off“ poklopcem (aluminij i plastika).
Powder: white to off-white Solvent: clear solution
Prašak: bijele do gotovo bijele boje Otapalo: bistra otopina
powder:10 mg; solvent: 1.5 ml
prašak:10 mg; otapalo: 1,5 ml
POWER 1 and POWER 2 pooled data
Objedinjeni podaci ispitivanja POWER 1 i POWER 2
POWER 1 and POWER 2 trials.
POWER 1 i POWER 2.
Power frequency magnetic fields should be at levels characteristic of a typical location in a typical commercial or hospital environment.
Magnetska polja frekvencije jednake frekvenciji napajanja trebala bi biti na razinama karakterističnima za tipičnu lokaciju u tipičnom komercijalnom ili bolničkom okruženju.
PP (per protocol) Population
Populacija po protokolu (PP)
PP = Per Protocol Population; ITT = Intent To Treat Population
PP = populacija koja je završila ispitivanje prema planu ispitivanja (engl. per protocol); ITT = populacija predviđena za liječenje (engl. intent-to-treat)
PP-population
PP populacija
PP-population*
PP populacija
PP/Aluminium foil blister.
Blister od PP/alumijske folije
PP/Aluminium foil blister.
Blister od PP/alumijske folije.
PP/Aluminium foil blisters in a wallet containing 42 film-coated tablets Xarelto 15 mg and 7 film- coated tablets Xarelto 20 mg (treatment initiation pack).
PP/aluminij blisteri u ovitku oblika novčanika koji sadrži 42 filmom obložene tablete lijeka Xarelto 15 mg i 7 filmom obloženih tableta lijeka Xarelto 20 mg (pakiranje za početak liječenja).
PP/Aluminium foil blisters in cartons of 10, 14, 28 or 98 film-coated tablets or perforated unit dose blisters in cartons of 10 x 1, or 100 x 1 or in multipacks containing 100 (10 packs of 10 x 1) film- coated tablets.
PP/aluminij blisteri u kutijama s po 10, 14, 28 ili 98 filmom obloženih tableta ili perforirani blisteri djeljivi na jedinične doze u kutijama od po 10 x 1, 100 x 1 ili višestruka pakiranja koja sadrže 100 (10 pakiranja od 10 x 1) filmom obloženih tableta.
PP/Aluminium foil blisters in cartons of 10, 14, 28, 42 or 98 film-coated tablets or perforated unit dose blisters in cartons of 10 x 1, or 100 x 1 or in multipacks containing 100 (10 packs of 10 x 1) film- coated tablets.
PP/aluminij blisteri u kutijama s po 10, 14, 28, 42 ili 98 filmom obloženih tableta ili perforirani blisteri djeljivi na jedinične doze u kutijama od po 10 x 1, 100 x 1 ili višestruka pakiranja koja sadrže 100 (10 pakiranja od 10 x 1) filmom obloženih tableta.
PP/Aluminium foil blisters in cartons of 14, 28, 30, 56, 60, 98, 168 or 196 film-coated tablets or perforated unit dose blisters in cartons of 10 x 1 or 100 x 1 or in multipacks containing 100 (10 packs of 10 x 1) film-coated tablets.
Blisteri od PP/aluminijska folija u kutijama s po 14, 28, 30, 56, 60, 98, 168 ili 196 filmom obloženih tableta ili perforirani blisteri djeljivi na jedinične doze u kutijama s po 10 x 1 ili 100 x 1 ili u višestrukim pakiranjima koja sadrže 100 (10 pakiranja od 10 x 1) filmom obloženih tableta.
PP/Aluminium foil blisters in cartons of 2, 4, 8, 12 and 20 tablets.
PP/Al blisteri u kutijama s 2, 4, 8, 12 ili 20 tableta.
PP/Aluminium foil blisters in cartons of 2, 4, 8, 12 and 20 tablets.
PP/aluminijski blisteri u kutijama s 2, 4, 8, 12 ili 20 tableta.
PP/Aluminium foil blisters or PVC/PVDC/Aluminium foil blisters in cartons of 5, 10 or 30 film- coated tablets or perforated unit dose blisters in cartons of 10 x 1 or 100 x 1 film-coated tablets.
PP/aluminij blisteri ili PVC/PVDC/aluminij blisteri u kutijama s po 5, 10 ili 30 filmom obloženih tableta ili perforirani blisteri djeljivi na jedinične doze u kutijama s po 10 x 1 ili 100 x 1 filmom obložena tableta.
PP/Aluminium foil perforated unit dose blisters in multipacks containing 100 (10 packs of 10 x 1) film-coated tablets.
PP/aluminij perforirani blisteri djeljivi na jedinične doze u višestrukim pakiranjima koja sadrže 100 (10 pakiranja od 10 x 1) filmom obloženih tableta.
PPE is characterised by painful, macular reddening skin eruptions.
PPE karakterizirajubolne, makularne erupcije po koži.
PPE*, alopecia, rash
PPE*, alopecija, osip
PR = progesterone receptor a ER/PR-negative or Grade 3 or tumor size >5 cm
ER = estrogenski receptor PR = progesteronski receptor a ER/PR-negativni ili gradus 3 ili veličina tumora >5 cm
PR48 (N=80)
PR48 (N= 80)
Prac-tic 137.5 mg Pyriprole
Prac-tic 137,5 mg Piriprol
Prac-tic 137.5 mg spot-on solution for small dogs
Prac-tic 137,5 mg spot-on otopina za male pse
Prac-tic 275 mg Pyriprole
Prac-tic 275 mg Piriprol
Prac-tic 275 mg spot-on solution for medium dogs
Prac-tic 275 mg spot-on otopina za pse srednje veličine
Prac-tic 56.25 mg Pyriprole
Prac-tic 56,25 mg Piriprol
Prac-tic 56.25 mg spot-on solution for very small dogs
Prac-tic 56,25 mg spot-on otopina za vrlo male pse
Prac-tic 625 mg Pyriprole
Prac-tic 625 mg Piriprol
Prac-tic 625 mg spot-on solution for large dogs
Prac-tic 625 mg spot-on otopina za velike pse
Prac-tic should not enter water courses as it may be dangerous for fish and other aquatic organisms.
Prac-tic ne treba odlagati u otvorene vode jer to može biti opasno za ribe i druge vodene organizme.
Prac-tic should not enter water courses as this may be dangerous for fish and other aquatic organisms.
Prac-tic ne treba odlagati u otvorene vode jer to može biti opasno za ribe i druge vodene organizme.
Prac-tic spot-on for dogs Pyriprole
Prac-tic spot-on otopina za pse Piriprol
Prac-tic spot-on solution for dogs
Prac-tic spot-on otopina za pse
Practical details on the preparation of the solution for infusion
Praktični detalji o pripremi otopine iza infuziju
Practical details on the preparation of the solution for infusion
Praktični detalji o rekonstituciji otopine za infuziju
Practical details on the reconstitution of vials
Praktični detalji o rekonstituciji otopine u bočicama
Practical details on the reconstitution of vials
Praktični opis pripreme otopine u bočicama
Practical Information
Praktične informacije
Practical information for handling and administration of ZALTRAP for doctors, nurses and pharmacists when using this medicine, is provided with this leaflet.
Praktične informacije za rukovanje i primjenu lijeka ZALTRAP za liječnike, medicinske sestre i ljekarnike uključene su u ovu uputu.
PRACTICAL INFORMATION FOR HEALTHCARE PROFESSIONALS
PRAKTIČNE INFORMACIJE ZA ZDRAVSTVENE DJELATNIKE
PRACTICAL INFORMATION FOR MEDICAL OR HEALTHCARE PROFESSIONALS ON PREPARATION, ADMINISTRATION AND HANDLING OF JEVTANA 60 mg CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION
PRAKTIČNE INFORMACIJE ZA ZDRAVSTVENE DJELATNIKE O PRIPREMI, PRIMJENI I RUKOVANJU LIJEKOM JEVTANA 60 mg KONCENTRAT I OTAPALO ZA OTOPINU ZA INFUZIJU
Pradaxa (dabigatran etexilate) treatment can be re-initiated 24 hours after administration of Praxbind, if the patient is clinically stable and adequate haemostasis has been achieved.
Liječenje Pradaxom (dabigatraneteksilatom) se može ponovo početi 24 sata nakon primjene Praxbinda, ako je bolesnik klinički stabilan te je postignuta odgovarajuća hemostaza.
Pradaxa 110 mg (only applicable for folding box, not applicable for bottle label)
Pradaxa 110 mg (primjenjivo samo za kutiju, nije primjenjivo za naljepnicu na boci)
Pradaxa 110 mg are hard capsules with an opaque, light blue-coloured cap and an opaque, cream-coloured body.
Pradaxa 110 mg su tvrde kapsule s neprozirnom, svijetloplavom kapicom i neprozirnim tijelom krem boje.
Pradaxa 110 mg hard capsules
Pradaxa 110 mg tvrde kapsule
Pradaxa 110 mg hard capsules are also available in polypropylene (plastic) bottles with 60 hard capsules.
Pradaxa 110 mg tvrde kapsule također su dostupne u polipropilenskoj (plastičnoj) boci sa 60 tvrdih kapsula.
Pradaxa 110 mg hard capsules Dabigatran etexilate
Pradaxa 110 mg tvrde kapsule dabigatraneteksilat
Pradaxa 150 mg (only applicable for folding box, not applicable for bottle label)
Pradaxa 150 mg (primjenjivo samo za kutiju, nije primjenjivo za naljepnicu na boci)
Pradaxa 150 mg are hard capsules with an opaque, light blue-coloured cap and an opaque, cream-coloured body.
Pradaxa 150 mg su tvrde kapsule s neprozirnom, svijetloplavom kapicom i neprozirnim tijelom krem boje.
Pradaxa 150 mg hard capsules
Pradaxa 150 mg tvrde kapsule
Pradaxa 150 mg hard capsules are also available in polypropylene (plastic) bottles with 60 hard capsules.
Pradaxa 150 mg tvrde kapsule također su dostupne u polipropilenskoj (plastičnoj) boci sa 60 tvrdih kapsula.
Pradaxa 150 mg hard capsules Dabigatran etexilate
Pradaxa 150 mg tvrde kapsule dabigatraneteksilat
Pradaxa 75 mg (only applicable for folding box, not applicable for bottle label)
Pradaxa 75 mg (primjenjivo samo za kutiju, nije primjenjivo za naljepnicu na boci)
Pradaxa 75 mg are hard capsules with an opaque, light blue-coloured cap and an opaque, cream-coloured body.
Pradaxa 75 mg su tvrde kapsule s neprozirnom, svijetloplavom kapicom i neprozirnim tijelom krem boje.
Pradaxa 75 mg hard capsules
Pradaxa 75 mg tvrde kapsule
Pradaxa 75 mg hard capsules Dabigatran etexilate
Pradaxa 75 mg tvrde kapsule dabigatraneteksilat
Pradaxa affects blood clotting, so most side effects are related to signs such as bruising or bleeding.
Pradaxa utječe na zgrušavanje krvi, tako da je većina nuspojava povezana je sa znakovima kao što su pojava modrica ili krvarenje.
Pradaxa and these medicines should be taken at the same time.
Pradaxa i navedeni lijekovi se uzimaju u isto vrijeme.
Pradaxa and verapamil-containing medicines should be taken at the same time.
Pradaxa i lijekovi koji sadrže verapamil uzimaju se u isto vrijeme.
Pradaxa can be taken with or without food.
Pradaxa se može uzeti sa ili bez hrane.
Pradaxa can be taken with or without food.
Pradaxa se može uzimati sama ili bez hrane.
Pradaxa can be takenwith or without food.
Pradaxa se može uzeti sa ili bez hrane.
Pradaxa contains sunset yellow (E110)
Pradaxa sadrži boju sunset yellow (E110)
Pradaxa dabigatran etexilate
Pradaxa dabigatran eteksilat
Pradaxa hard capsules contain the colorant sunset yellow (E110), which may cause allergic reactions.
Pradaxa tvrde kapsule sadrže boju „sunset yellow” (E110), koja može uzrokovati alergijske reakcije.
Pradaxa has no known effects on the ability to drive or use machines.
Pradaxa nema poznatih učinaka na sposobnost upravljanja vozilima i rada sa strojevima.
Pradaxa has no or negligible influence on the ability to drive and use machines.
Pradaxa ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
Pradaxa is a blood thinner medicine that lowers the risk of blood clot formation.
Pradaxa je antikoagulans koji smanjuje rizik stvaranja krvnih ugrušaka.
Pradaxa is a medicine that contains the active substance dabigatran etexilate.
Pradaxa je lijek koji sadrži djelatnu tvar dabigatran eteksilat.
Pradaxa is a medicine which contains the active substance dabigatran etexilate.
Pradaxa je lijek koji sadrži djelatnu tvar dabigatraneteksilat.
Pradaxa is a medicine which is used to reduce the risk of brain or body vessel obstruction by blood clot formation in adult patients with an abnormal heart beat (atrial fibrillation) and additional risk factors.
Pradaxa je lijek koji se primjenjuje za smanjenje rizika od moždanog udara ili začepljenja krvnih žila krvnim ugrušcima u bolesnika s abnormalnim otkucajima srca (fibrilacija atrija) te dodatnim čimbenicima rizika.